Loading...

Dr. Suzanne Topalian on the PD-1 Targeted Therapy BMS-936558

2,703 views

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jun 1, 2012

Suzanne Topalian, MD, Professor of Surgery and Oncology at the Johns Hopkins University School of Medicine, discusses early-stage results of the targeted immune agent BMS-936558, a co-inhibitor of the programmed death-1 (PD-1) receptor that is expressed by activated T cells.

Find out more at http://www.onclive.com/conference-cov...

Loading...

to add this to Watch Later

Add to

Loading playlists...